Description:
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION; PKAN; HALLERVORDEN-SPATZ DISEASE INCLUDED
PANTOTHENATE KINASE 2; PANK2
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Class |
Disorders of the Nervous System |
Quantity |
25 µg |
Quantitation Method |
Please see our FAQ |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
DNA from LCL
|
Race
|
White
|
Ethnicity
|
AMISH/SWISS
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase,Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
|
Gene |
PANK2 |
Chromosomal Location |
20p13-p12.3 |
Allelic Variant 1 |
606157.0001; PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION |
Identified Mutation |
7-BP DEL, NT627; In an individual with classic pantothenate kinase-associated neurodegeneration (234200), Zhou et al. [Nature Genet. 28: 345-349, (2001)] identified a frameshift mutation in exon 2 in homozygosity. |
|
Gene |
PANK2 |
Chromosomal Location |
20p13-p12.3 |
Allelic Variant 2 |
606157.0001; PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION |
Identified Mutation |
7-BP DEL, NT627; In an individual with classic pantothenate kinase-associated neurodegeneration (234200), Zhou et al. [Nature Genet. 28: 345-349, (2001)] identified a frameshift mutation in exon 2 in homozygosity. |
Remarks |
Clinically affected; Amish of Swiss descent; severe dystonia; pigmentary retinopathy; progression to nonambulation early in the second decade; dysarthria; spasticity and rigidity; donor subject is homozygous for a 7-bp deletion in exon 2 of the PANK2 gene which results in a frameshift. |
Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ, A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet28(4):345-9 2001 |
PubMed ID: 11479594 |
|
Taylor TD, Litt M, Kramer P, Pandolfo M, Angelini L, Nardocci N, Davis S, Pineda M, Hattori H, Flett PJ, Cilio MR, Bertini E, Hayflick SJ, Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13. Nat Genet14(4):479-81 1996 |
PubMed ID: 8944032 |
|
|